Rockefeller Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-153
Closed -$3K 3915
2022
Q2
$3K Sell
153
-211,636
-100% -$4.15M ﹤0.01% 3622
2022
Q1
$11.6M Buy
211,789
+10,878
+5% +$598K 0.06% 326
2021
Q4
$13.3M Buy
200,911
+6,682
+3% +$442K 0.06% 297
2021
Q3
$16.3M Buy
194,229
+2,938
+2% +$247K 0.09% 243
2021
Q2
$24.3M Buy
191,291
+2,357
+1% +$299K 0.14% 174
2021
Q1
$20.7M Sell
188,934
-270
-0.1% -$29.6K 0.14% 169
2020
Q4
$27M Sell
189,204
-678
-0.4% -$96.8K 0.2% 120
2020
Q3
$13.4M Buy
189,882
+24,339
+15% +$1.72M 0.13% 168
2020
Q2
$11.6M Buy
165,543
+13,728
+9% +$961K 0.12% 169
2020
Q1
$5.31M Buy
+151,815
New +$5.31M 0.07% 215
2019
Q4
Sell
-5,214
Closed -$175K 2065
2019
Q3
$175K Buy
5,214
+1,949
+60% +$65.4K ﹤0.01% 659
2019
Q2
$85K Buy
+3,265
New +$85K ﹤0.01% 722
2018
Q4
Sell
-9,231
Closed -$231K 904
2018
Q3
$231K Buy
+9,231
New +$231K ﹤0.01% 334